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Abstract 
 
Objectives: Depression presents one of the biggest global health concerns today. According to the 
network theory, mental disorders, such as depression, reflect co-occurring intercorrelating symptom 
effects. Thus, studying the properties of depressive symptom networks could enhance knowledge 
about the etiology of depression. In this study, network structures of men and women of the general 
population are compared, to enhance understanding of higher prevalence rates of depression in 
women. Although gender differences of depression are widely studied, this is the first study 
comparing the depressive symptom network structures of adult men and women in the general 
population. 
Methods: The data (n = 567 men; n= 886 women) are from a national age cohort study (LASER). 
Partial correlation networks of BDI-II symptoms were compared in two time-points. 
Results: Estimated networks had distinct gender differences. Men had lower mean scores, but more 
changes in the network structure across time, more negative edges, and higher network density. 
“Agitation” was highly central only in the men’s networks. Women showed changes in mean sum 
scores, but network structures had few changes, and symptoms formed three distinct communities in 
both time-points. “Fatigue” was reported significantly more by women and was highly central only 
in the women’s networks.  
Implications: Differences in symptom networks between men and women may explain the gender-
related differences in the prevalence of depression. Negative edges in the men’s networks and the 
symptom communities in the women’s networks are targets for more research. Fatigue could be a 
valuable target for preventing and treating women’s depression.  
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1 INTRODUCTION 
Depression is one of the lead causes of disability in western societies, and over 300 million people 
are affected by it worldwide (WHO, 2018). It represents one of the most profound global health 
problems humans face today (Greden, 2001). Despite decades of research, depression remains 
challenging to treat, depressive episodes are often reoccurring, and residual symptoms after remission 
common (Holtzheimer & Nemeroff, 2006). Depression manifests in an array of cognitive, social, 
emotional, and physical symptoms, and the costs are high to the individuals affected by it, as well as 
to the society (Greden, 2001). Women are more likely to suffer from depression, showing around a 
2:1 ratio of major depression diagnoses compared to men, and the gender difference in depression is 
well established and seen across nations (Salk, Hyde & Abramson, 2017). 
 
Individuals with a depression diagnosis can express a multitude of symptom combinations. In a recent 
study, of 3703 clinically assessed depressed individuals, it was found that only 1.8% share the same 
combination of depressive symptoms (Fried & Nesse 2015a). Although different symptoms have 
different social, cognitive, and neurobiological origins, resulting in a heterogeneous clinical picture 
of depression, research does not traditionally focus on the symptom level. The network approach to 
mental disorders, is a new framework for understanding and studying mental disorders, which 
emphasizes the role of individual symptoms and relationships between symptoms (Borsboom & 
Cramer, 2013; Fried, 2015). This study aims to enhance understanding of the gender difference in 
depression by investigating the architecture and severity of depressive symptoms of men and women.  
1.1 MAJOR DEPRESSIVE DISORDER 
Depressive disorders, particularly the main diagnosis of ‘major depressive disorder' (MDD), belongs 
to the family of mood disorders, and is characterized by life disruptive symptoms, such as negative 
emotionality, sadness, hopelessness, and anhedonia. According to the current edition of the 
Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2015; 
DSM-V) an episode of major depression can be diagnosed when five out of 9 possible symptoms 
have persisted for at least two weeks and are causing the individual clinically significant distress and 
impairment. One of the symptoms must be 1) depressed mood or 2) loss of interest, which constitute 
higher-level symptoms of MDD diagnosis.  The other seven symptoms are 3) significant weight loss 
or gain, or a decrease or increase in appetite, 4) insomnia or hypersomnia 5) an increase or a slowing 
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down /reduction of thought and of physical movement (psychomotor agitation or retardation), 6) 
fatigue or loss of energy, 7) feelings of worthlessness or excessive or inappropriate guilt, 8) 
diminished ability to think or concentrate, or indecisiveness, and 9) recurrent thoughts of death, 
recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for 
committing suicide. In a recent Epidemiology of Adult DSM-5 Major Depressive Disorder based on 
36 309 US adult participants (Hasin et al., 2018) the estimated 12-month prevalence rate of MDD is 
10.4% and the lifetime prevalence rate is 20.6% respectively. According to the same study, co-
occurrence with other disorders is high, ranging from 36.4% comorbidity with anxiety disorders, 
40.9% with personality disorders, and 45.3% with substance use. According to a World Health 
Organization estimate, the prevalence of depressive disorders in the European region ranges between 
3.5-5% of all citizens (WHO, 2017).  
 
The cost of depression can be devastating for the individuals affected by it, as it causes impairment 
in cognitive (Greden, 2001), emotional (Beck, 2002), social (Kessler, 2012) and physical functioning 
(Moussavi et al., 2007). The effects can be debilitating and be disruptive to crucial areas of life. Often 
episodes of depression coincide with transitional periods of development, which can lead to 
termination of education, marital dissatisfaction, divorce, negative parenting behavior, and reduced 
work performance (Kessler, 2012). In the WHO World Health Survey, based on observations from 
245 404 participants from 60 countries, depression was seen to have the most significant decrement 
in health, when compared to other chronic diseases, such as angina, diabetes, arthritis or asthma 
(Moussavi et al., 2007). According to the same study, a physical illness with comorbid depression is 
also associated with worse health compared to just having one or the other. Depression can ultimately 
lead to suicide, and nearly 800 000 people die due to suicide annually (WHO, 2015). The cost of 
depression among other mental illnesses is significant also in monetary value. An OECD report 
estimated that the cost of mental illness amounts to more than 4% across EU countries, equivalent to 
over 600 billion euros per year. These costs include health service costs, social security programs, 
lost earnings and lower productivity (OECD/EU, 2018). Additional costs relating to informal care 
that is provided by family and friends, or other public service costs are harder to estimate (Center for 
Mental Health, 2010). Hence, developing more effective ways to prevent and treat mental illnesses, 
such as depression, remains a highly relevant topic in research.   
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1.2 GENDER DIFFERENCES IN DEPRESSION CHARACTERISTICS 
Women are found more susceptible to depression across nations compared to men (Weissman, 1993; 
Angst et al., 2002; Van de Velde, Bracke & Levecque, 2010). The gender difference is seen in 
diagnoses of MDD, as well as in the severity of depression symptoms. In recent large meta-analyses, 
based on representative cross-national samples, females showed a higher ratio of depression 
diagnoses (OR= 1.95; d=0.37) and larger mean differences in depression symptoms (d=0.27) 
compared to men (Salk, Hyde & Abramson, 2017). There is a consistency in both analyses that the 
gender difference peaks in adolescence, then declines and remains stable until late mid-life (at around 
d=0.19-0.3 for both diagnoses and symptoms) (Salk, Hyde & Abramson, 2017).   
 
Besides overall severity in symptoms sum scores, significant differences are reported in various 
symptoms between genders. Schuch et al. (2014) compared 30 depression symptoms in a nationally 
representative sample based on and found 11/30 significant differences in symptoms between men 
and women. The differences included men experiencing more "sad mood" (p<.01) and "loss of 
interest" (p=.01), and women experiencing more "increased weight" (p<.01), somatic 
(pain)complaints (p=.01), panic/phobic symptoms (p=.02), gastrointestinal complaints (diarrhea, 
constipation) (p=.04), increased interpersonal sensitivity (p<.01) and "mid-nocturnal insomnia" 
(p=.01). Women are seen to have more atypical symptoms of depression, such as hypersomnia and 
increase in weight/appetite (Angst et al., 2002) and present more comorbidity with anxiety-related 
symptoms and lower social functionality, whereas men consume more alcohol (Kornstein et al., 1995; 
Schuch et al., 2014).   
 
Besides differences in prevalence rates of diagnoses and symptoms, neurobiological evidence 
indicates that processes on the molecular and neurobiological level, associated with MDD, vary 
depending on gender. Firstly, neurochemical differences are seen in growth factors, which are 
involved in regulating neural plasticity and seen in lower levels in depressed patients compared to 
healthy controls. The Brain-derived neurotrophic factors (BDNF) is seen associated with the duration 
of a depressive episode in women, but not in men, and in contrast the nerve growth factor (NGF) 
shows significant association with the duration of an MDE with men, but not in women respectively 
(Cardoso et al., 2014). Alterations in associations to MDD depending on gender are also seen in the 
functions of the endocrine system (e.g., the hypothalamic-pituitary–adrenal-axis (HPA-axis) and/or 
sex steroids), inflammation, hormones and metabolic functioning (e.g. leptin or glucocorticoids), 
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which all show clear associations with mood disorders (Schmidt, Shelton & Duman, 2011; Pariante, 
2009; Pariante & Miller, 2001; Hryhorczuk, Sharma & Fulton, 2013). 
 
For example, in line with the fact that depressed women show more symptoms of appetite changes, 
depressed women have a two-fold risk of having metabolic abnormalities compared to men ( 
Hryhorczuk, Sharma & Fulton, 2013). There is also clear evidence that dysregulation of the HPA-
axis is associated with mood disorders (Pariante, 2009; Pariante & Miller, 2001), and women seem 
to be more susceptible to the dysregulation of the HPA-axis (Weiss, Longhurst & Mazure, 1999). 
Inflammation molecules, on the contrary, are seen in increased levels in depression in men, but not 
in women, suggesting that men might be more prone to an inflammatory basis of depression 
(Elovainio et al., 2009; Ramsey et al., 2014). Sex steroids in men and gonadal hormones in women 
are linked to several neurobiological mechanisms and associations to MDD, including gender-related 
vulnerabilities to comorbidity of substance use in men and atypical symptoms in women (Walther et 
al., 2017; Halbreich & Kahn, 2007). The gender difference seen in the prevalence rates of depression 
are likely to be a mixture of biological, social and psychological factors. Investigating the gender 
difference on a symptom level may enhance our understanding of the developmental differences in 
depressive episodes and enable more specific hypothesis and targets for interventions and prevention.   
1.3 PROBLEMS IN TRADITIONAL DIAGNOSTIC CLASSIFICATION  
The current diagnostic system is an attempt to categorize and classify recognized symptom patterns 
that are seen in psychiatric patients. It is acknowledged that some symptoms, such as symptoms of 
MDD, are more likely to co-occur together compared to symptoms under another diagnostic label. 
Although having explicit diagnostic criteria have helped advance research and clinical practice, there 
are also concerns relating to the conceptual development of the current diagnostic system (Regier, 
Narrow, Kuhl & Kupfer, 2009). The biggest concern relates to high comorbidity between disorders, 
which implies that there is no clear separation between disorders. A problem, which follows from the 
overlapping of different disorders, is that individuals sharing the same diagnostic labels have many 
altering symptoms.  
 
The problem of heterogeneity is also apparent in the context of MDD (Goldberg, 2011). Numerous 
different combinations can lead to a diagnosis of MDD according to the DSM-5, and two patients 
might only share one symptom in common. Some symptoms include their opposites, such as 
hypersomnia or insomnia, weight gain or weight loss, restlessness, or retardation of movements. To 
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classify the diverse clinical presentations of depression, the DSM-5 includes subtypes of major 
depression, with atypical, anxious, psychotic, or mixed features. Depressive disorders differ in their 
combinations of symptoms, onset or level of severity, and often, although more ambiguously, a 
diagnosis may include additional symptoms, unspecified labels, or comorbid diagnoses. As a result, 
patients with a depression diagnosis vary considerably in clinical presentations, genetics, 
neurobiology, clinical course, treatment responsiveness, and biological correlates (Rush, 2007; Fried 
& Nesse, 2015a).   
 
So far, there are no biomarkers that are used to predict clinical outcomes, the development of effective 
treatments has been slow, and treating MDD is still very challenging (Holtzheimer, 2006). The 
effectiveness of a single treatment of anti-depressant medication in non-chronic patients with MDD 
is only at around 30% - 45% (Thase, Entsuah, & Rudolph, 2001). Moreover, approximately 20-30% 
of individuals with MDD have chronic treatment-resistant depression after sequential drug- and 
therapy interventions (Howland, 2014). Even for those who respond to treatment, relapse is prevalent, 
and the majority of individuals with MDD have residual symptoms (Fava & Rush, 2006). In clinical 
work, the heterogeneity of clinical presentations is recognized, as people rarely depict a clear cut 
"depression" or "anxiety," but more than often, they have multiple problems (Frank & Davidson, 
2014). Many patients also experience problems, which are clinically significant but do not meet any 
existing diagnostic category (Löwe et al., 2008). In clinical work, clinicians have developed ways to 
get around complex issues and comorbidity by targeting common cognitive, emotional and behavioral 
mechanisms, that are seen across various disorders (Frank & Davidson, 2014).    
 
The current diagnostic model assumes that the covariation between symptoms is due to a latent 
common cause, e.g. ‘major depression'. This traditional conceptualization of mental disorders 
represents an influential 20th-century single perspective explanatory model of psychopathology, 
which has been argued to resemble the disease model of medical science (Kendler, 2008; Borsboom 
& Cramer, 2013). According to the disease model, a distinct medical entity (such as a tumor) can 
cause symptoms, such as headaches, forgetfulness, and foggy eyesight (Borsboom & Cramer, 2013). 
However, mental disorders are increasingly seen to be influenced by multicausal psychological, 
social, and biological processes both within and outside the individual, which are difficult to explain 
to result from a common cause perspective. As a result, in the field of psychiatry and clinical 
psychology, the analogy is challenged. New explanations have become more pluralistic and 
multilevel (Kendler, 2008; Cramer 2013; Borsboom, Cramer & Kalis, 2018), that can better account 
for the high comorbidity rates and the psychological phenomena, that are seen across traditional 
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diagnostic categories. Examples of prominent new frameworks for studying psychopathology include 
higher-order externalizing and internalizing dimensions (Kessler, Petukhova & Zaslavsky, 2011), the 
RDoC project (NIMH, 2008), or the network approach to mental disorders which places symptoms 
in the focal point of psychopathology (Borsboom, Cramer & Kalis, 2018; Borsboom & Cramer, 
2013). 
1.4 DEPRESSION AS A DYNAMIC SYSTEM  
The network approach to mental disorders is a new framework for studying and conceptualizing 
psychopathology as dynamic symptom networks. Symptoms are seen to have direct relationships, 
which causes covariation between symptoms. In other words, mental disorders are conceptualized, as 
the emergent property of co-occurring and intercorrelating (and causal) symptom effects, instead of 
latent variables (Borsboom, 2017; Fried, 2015). Symptoms can be activated by other symptoms 
and/or a multitude of internal or external factors (e.g., loss of a spouse, catastrophic thinking or 
neurobiological dysfunction), making the connections highly multifactorial (Borsboom, Cramer & 
Kalis, 2019). For example, an external event of stress may lead to concentration problems, which 
may lead to sleep problems, which may lead to fatigue and depressed mood. The displays of current 
disorders are explained as endless variations of complex networks of symptoms, where the focus of 
research is placed on the connections between items in the network.  
 
The relationships between symptoms are the basis for understanding mental health and illness in the 
network framework. When symptoms connect strongly, the activation of one symptom (e.g., worry) 
can lead to the activation of other symptoms more easily (e.g. loss of sleep, anxiety, concentration 
problems) (Cramer et al., 2016). When enough symptoms are activated, causal relationships between 
them can create dynamic networks, feedback loops and self-sustaining structures, which can remain 
active, even after the external stressor has passed (Borsboom, 2017). A recovery from an episode 
happens when connections between symptoms dissolve or symptoms deactivate. In remission, the 
network returns to a state of equilibrium, where the self-sustaining parameters of symptom activity 
rest below a threshold value (Borsboom, 2017).    
 
In this framework, comorbidity and heterogeneity are natural consequences of the network structure, 
as symptoms may act as bridges to other symptoms across traditional diagnostic categories 
(Borsboom & Cramer, 2013). Furthermore, each person has their unique symptom networks, causal 
pathways and connections, vulnerabilities, and risk factors in developing episodes of mental distress 
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(Borsboom & Cramer, 2013). The ontological insights of the network approach have laid a basis for 
a growing number of methodological tools and techniques for visualizing and comparing patterns of 
network interactions and properties. The application of network analysis is rapidly growing, and it 
has been used to study the interactions of symptoms for many diagnostic categories and comorbid 
disorders, such as depression and anxiety (reviews of the application of network analysis: Conteras 
et al., 2019; Fried et al., 2017). The new insights network studies reveal about symptom interactions 
may help form new hypotheses, guide the development of novel interventions, and increase 
understanding of depressive illnesses (McNally, 2016).  
1.5 NETWORK ANALYSIS OF DEPRESSION 
The most commonly used network with psychological data is a weighted partial correlation network, 
which consists of nodes (variables) and edges (connections between nodes) (Eskamp, Borsboom, & 
Fried, 2018). A weighted network means that the connections in the network have altering magnitudes 
(Constantini et al., 2015). Partial correlations are the pairwise values derived from an inverse of a 
covariance matrix. The values reflect direct associations between two items after controlling 
information from all other items. This means, that partial correlations are especially suitable for 
revealing interactions between symptoms. With the use of typical correlations, a connection between 
two items could be due to shared connections to other items. However, in a partial correlation 
network, an edge between two nodes, depicts an association between the nodes after controlling 
information from all other nodes (Constantini et al., 2015). There are already several studies, which 
have utilized the network approach to reveal symptom associations, risk and protective factors, the 
course of illness and characteristics of depression, and the number of network studies is rapidly 
increasing (Fried et al., 2017).  
1.5.1 The concept of centrality 
Symptom networks can be assessed on both local and global levels (Constantini et al., 2015). On the 
local level, centrality measures can be calculated for individual nodes, which indicate the magnitude 
of connections a node has to other nodes. A symptom which has high centrality is likely to influence 
or be influenced by other symptoms more easily, compared to symptoms with weak connections. 
Many studies use different variables, so a comparison between centralities in different studies is 
difficult (Fried et al., 2017). Similarly, different network analysis techniques, or factors such as 
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whether the study was cross-sectional or temporal, hamper comparisons. However, there is some 
consistency regarding the centrality of depressive symptoms.   
 
Several studies have shown similar results, that the two core items of DSM-5 "depressed mood" and  
"loss of interest" and the two non-core DSM-items of "concentration problems" and "fatigue/energy 
loss," are central symptoms in depression symptom networks among both depressed individuals 
(Fried et al., 2016a; Boschloo, van Borkulo, Borsboom, & Schoevers, 2016). Furthermore, centrality 
measures are associated with the course of illness in depression. For example, “depressed mood, "loss 
of interest", "concentration problems" and "fatigue" were found to predict the onset of a later 
diagnosis of major depression, in a study based on 501 participants, with no lifetime depressive or 
anxiety diagnosis in the baseline assessment of the Netherlands Study of Depression and Anxiety 
(Boschloo, van Borkulo, Borsboom, & Schoevers, 2016). The researchers found that “depressed 
mood, "loss of interest," "concentration problems" and "fatigue" were the strongest predictors for the 
onset of a later MDD, compared to other symptoms (r=.87, p< .001). 
 
A study by van Borkulo et al. (2015) looked at how centrality was associated with clinical outcomes 
in clinically depressed patients. They found that "feelings of guilt," "fatigue," and "loss of energy" 
were significantly more central in the baseline assessment of those patients with a persistent 
depression after two years, compared to patients with depression in remission after two years 
(difference in node strength: "feelings of guilt": Cohen d=1,18; "fatigue/loss of energy": Cohen 
d=1,13). "Fatigue" has been associated with worse treatment outcomes also with adolescents. In a 
prospective study, that compared the network structure of adolescents undergoing treatment for 
depression symptoms (McElroy, Napoleone, Wolpert & Patalay, 2019), "fatigue" was the most 
central symptom at baseline for those who did not improve. Interestingly, "low mood" was the most 
central symptom at baseline for those who responded positively to treatment.  
 
It is possible that when depression is accompanied by "feelings of guilt," "fatigue," and "loss of 
energy," depression may be more treatment-resistant. "Low mood" as the main problem, might 
instead yield better results in treatment. There is evidence that "depressed mood" (the equivalent of 
sadness), is associated with lower baseline severity (Ahmed, 2019) and that men are more prone to 
report symptoms of "sadness" (Schuch et al., 2014). In this light, "depressed mood" might be more 
central to men, whereas ‘feelings of guilt," "fatigue," and "loss of energy" might be more central to 
women. 
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1.5.2 The concept of density 
Similarly, as the strength of a single node suggests that the node is more pathogenic, a network having 
strong density (overall connectivity) is proposedly more pathogenic compared to a loosely connected 
network. In a dense network, symptom activation may spread easier and create “negative spirals” 
(Cramer, 2017). Density is calculated as the sum of absolute values of all edges. There is contradicting 
evidence whether denser networks are more pathogenic, or whether denser networks at baseline 
predict worse treatment outcomes of depression. According to network theory, in the same study as 
referred above, van Borkulo et al. (2015) found that patients who had a persistent depression had a 
more densely connected network at baseline compared to those who remained in remission. However, 
a study aiming to replicate the finding with a clinical sample of adolescents found no difference in 
network connectivity at baseline (Schweren et al., 2015). The direction of the association was the 
same none-the-less (Schweren et al., 2015). More recently, McElroy, Napoleone, Wolpert, and 
Patalay (2019) looked at routine psychiatric data from 3017 adolescents undergoing at least three 
sessions in publicly funded services. They found that looser baseline density was associated with 
better recovery. However, the group who had a weaker network density (profiting from treatment), 
also showed the largest increase in density during the intervention. The effect of increasing network 
density is reported with decreasing symptom severity also in other antidepressant-interventions 
studies of clinically depressed adults (Bos et al, 2018; Madhoo & Levine, 2016). These findings 
suggest that where less densely connected networks can be beneficial initially, stronger interaction 
between symptoms may support recovery from depression, indicating "positive spirals" in symptom 
interactions (McElroy, Napoleone, Wolpert, & Patalay, 2019).  
 
The role of density is an exciting topic of investigation, and there are still open questions regarding it 
(Fried et al., 2016b). For example, density has sometimes been reported higher among the general 
population compared to patient groups. An example of this was seen in a study with cancer patients 
(n=4020) who showed lower network density compared to controls (n=4020), although individuals 
with cancer experience more frequent and severe depressive symptoms (Hartung et al., 2019). 
Additionally, the lower network density in cancer patients was accompanied by lower symptom 
predictability compared to the general population. Symptom predictability depicts how much of the 
variance of a given symptom is explained by other symptoms in the network (Haslbeck and Fried, 
2017). Lower density and lower predictability suggest that the occurrence of depressive symptoms in 
cancer patients is affected by many other variables outside the network which was estimated in the 
study. Factors that could trigger depressive symptoms, could relate to the illness, be due to pain, 
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associate to cancer treatments or with neurological damage (Hartung et al., 2019). Reflecting on the 
results above, network density should be interpreted carefully, as higher density can be paired with 
lower mean values and lower severity of symptoms. Higher network density can be a sign of recovery 
and a "better working" network, on the contrary, what one may assume according to the current 
formulation of network theory (Cramer, 2017). Thus, the association between gender and density is 
difficult to assess a priori, as the implications of high/low density are unclear. These results also imply 
that although it is possible to graph networks, the context in which it interpreted is essential. 
Analyzing symptom predictability may increase the interpretability of the results.  
1.5.3 The concept of clustering 
The global structure of a symptom network can also be analyzed by looking at patterns, in which 
symptoms cluster together (Constantini et al., 2015). In network analysis clusters are often described 
as communities. A few studies report community structures of depressive symptoms. One study based 
on a clinical sample found two distinct communities which reflect atypical and melancholic subtypes 
of depression (Bringmann et al., 2015). In another study, three communities were found initially, and 
just as network density was seen to increase, communities saw an increase from three to five during 
a clinical intervention (Bos et al., 2018). As only a few studies have reported community structures 
of depressive symptoms among clinical samples, looking at the community structure of depressive 
symptoms networks of men and women, in a general population sample, is purely explorative.  
1.5.4 Comparing networks of men and women 
To my knowledge, two previous studies have examined the gender differences of depression from a 
network perspective. Firstly, van Borkulo et al. (2017) selected adult men (N=351) and women 
(N=709) with a past year major depressive order, from the Netherlands Study of Depression and 
Anxiety. They compared male and female cross-sectional symptom networks using the Network 
Comparison Test (NCT; van Borkulo et al., 2017), which was introduced in the same article. The 
NCT is a permutation technique that compares two independent networks to a network of subsamples 
drawn from the two datasets. The permutation technique can be used to compare the overall structure, 
network density (global strength) or differences between specific edge values or node centrality 
indices. It estimates networks using Pearson's correlations by default. There was no significant 
difference in the network structure between the two genders, resulting that no further investigation of 
density or specific edge differences was made.   
 
   11 
A second study (Mullarkey, Marchetti & Beevers, 2018) used the NCT to compare adolescent boys 
(N=646) and girls (N= 744) in a diverse community sample, who were assessed using the Children's 
Depression Inventory (CDI; Kovacs, 1985). They found a significant difference in the network 
structures (maximum difference = 1.16; p= .01), but not in network densities. A closer look at specific 
edge weights, using a Bonferroni-Holm correction, revealed that the only edge to significantly differ 
between the groups was the association between "body image" and "self-hatred," which was stronger 
in adolescent girls compared to boys (1.50 -0.34; p< .001). "Self-hatred" was one of the most central 
symptoms for both genders, along with "loneliness," "sadness" and "pessimism."   
 
The current investigation contributes to the ongoing investigation of gender differences in depression. 
This study complements the previous studies, which were based on an adult clinical sample and a 
community sample of adolescents, by looking at depression symptom networks of adult men and 
women in a large general population sample. A network analysis of depressive symptoms in the 
general population will give insight into whether there is a difference in symptom interactions at 
lower "baseline" levels between genders in adulthood. Replication studies, with large representative 
samples of individuals with recurrent depression, have shown that the network structure of depression 
symptoms show strong similarity in network structures across different levels of genetic and 
environmental risk factors (vanLoo et al., 2018). In this light, individuals who have been clinically 
diagnosed with depression may depict a more homogeneous group, compared to the general 
population, as they have all already been susceptible for developing major depression. An 
investigation of depressive symptom networks among the general population can shed light on why 
women are more vulnerable to develop depression in the first place. Comparing the networks in both 
local (centrality of specific nodes) and global levels (density, structure and clustering), will enable a 
sensitive analysis of gender-dependent dynamics of symptom interaction, which may have 
implications for the prognosis and prevention and intervention of MDD.  
2 RESEARCH QUESTIONS   
1. Are there differences in self-reported depressive symptom severity between men and women?  
2. Are there differences in the centrality of symptoms, community structure and/or overall 
connectedness in the depression symptom networks between men and women?  
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3. Do the network structures change correspondingly between genders, assessed by network 
properties in two time-points.   
3 METHOD  
3.1 PARTICIPANTS  
The participants (female N=882, male N=576) are part of an ongoing Young Finns age cohort study 
that started in 1980. The first sample of 4320 children and adolescents aged 3, 6, 9, 12, 15, 18 was 
randomly chosen from the Finnish national registry. This study will look at data from 2007 and 2012 
from participants who finished all questions relating to depressive symptoms in both time points. The 
participants' age ranged from 30 to 45 years old in the 2007 sample, and 35 to 50 years in the 2012 
sample respectively. Only those participants who filled in the whole questionnaire at both time points 
were included in the study.   
3.2 BDI-II  
Beck's depression inventory II (BDI-II: Beck, Steer & Brown, 1996) is a multiple-choice self-report 
inventory for assessing depressive symptoms of adults and children over 12. In Beck's theory, a 
wholesome negative way for evaluating one's self, experiences, and future provides reason for 
depression symptoms to arise. BDI-II is based on Aaron T. Beck and his colleague's original version 
of the inventory in 1961 and has been modified to reflect the depression symptomology of DSM-IV 
(Beck, Steer & Brown, 1996). The inventory consists of 21 multiple choice question on a four-
measure scale (0-3). The sum score of the items reflect severity, which ranges from no depression (0-
13), to mild depression (14-19), to moderate depression (20-28) to severe depression (29-63).  
However, the BDI-II is not a diagnostic tool, and a high score does not necessarily reflect severe 
depression. The internal consistency measured by Cronbach's Alpha, was very good in all samples, 
ranging between .96-.97.  
 
Bootstrapping resampling method (Efron, 1982) was used to compare mean sum scores between 
samples, as the method is especially valid when data are skewed, have unequal sample sizes or outliers 
(Howell, 2009). In comparison, outliers easily influence the Wilcoxon-test for non-parametric data 
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and, and the t-test assumes normally distributed data. Thus, means were compared by drawing 10,000 
subsamples from the original data and computing the mean each time. The process creates a 
distribution of means for each sample. The means of the two distributions can then be compared with 
a t-test (Howell, 2009). Bootstrapping was also used to obtain confidence intervals (CIs) for symptom 
mean scores. Each symptom was resampled 10,000 times and the mean of the subsample was 
recalculated each time. Means were reorganized in numerical order and 2,5% was cut from both ends 
of the resampled mean distribution to obtain 95% CIs. This procedure was repeated for each symptom 
distribution across all samples.  
3.3 NETWORK ANALYSIS  
The symptom networks in this study are partial correlation networks, which are based on a Gaussian 
graphical model (GGM; Laurizen, 1996) and most commonly used with psychological data 
(Epskamp, Borsboom, & Fried, 2018). The GGM can be used with ordinal data, as is the case with 
this data. The partial correlations, in this study, are based on threshold functions and polychoric 
correlations, which is common with non-normal ordinal data (Epskamp, Borsboon, & Fried, 2017; 
Muthén, 1984). As explained in more detail by Muthén (1984), a latent score threshold is calculated 
for each answering category (0, 1, 2, 3) along the Gaussian curve. Correlations between latent 
variables can then be estimated pairwise, without further transformations, using the threshold 
estimates.   
3.3.1 Network estimation 
Graphical LASSO regularization (glasso: (Friedman, Hastie, & Tibshirani, 2008) was used, which is 
specifically aimed at partial correlations (Epskamp, Borsboom, & Fried, 2018). Regularization cleans 
off very weak connections in the network, by limiting the sum of absolute partial correlation 
coefficients. As a result, all estimates shrink and some edges are reduced to zero (meaning the absence 
of an edge). By limiting the number of edges, the network becomes more interpretable. Regularization 
creates a pool of possible networks and the best-regularized network was selected by using EBIC-
model selection. The EBIC selection minimizes the Extended Bayesian Information Criterion (BIC) 
(Chen & Chen, 2008), and has been found both sensitive and especially good in retrieving the true 
network with a moderately large n and glasso regularization (Foygel & Drton, 2010). The EBIC 
hyperparameter λ was set to 0.5 as suggested by Foygel and Drton (2010). Symptom networks were 
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estimated using the R-package bootnet function ‘estimateNetwork' and plotted using the R-package 
qgraph function ‘plot'.  
 
Network comparisons were conducted by visual assessment. The NCT, which has been used in 
previous studies cannot be applied to this data, as it is based on Pearson’s correlations or binary data. 
Enabling comparisons, all networks were standardized by setting the maximum value to correspond 
with the largest maximum value of 0.62. Furthermore, to ease comparison, the layouts of the networks 
were averaged with the qgraph function ‘averageLayout'. Analyses were executed using the statistical 
computing software R 3.4.4 (R-Core team, 2014). A full R-script of the analyses is found in the 
Appendix, as is encouraged in the network literature (Epskamp, Borsboom, & Fried, 2018). 
3.3.2 Centrality, predictability and community structure 
Strength (Opsahl, Agneessens, & Skvoretz, 2010) and Expected Influence (Robinaugh, Millner & 
McNally, 2016) centralities were estimated using the bootnet-package in R (Epskamp, Borsboom, & 
Fried 2017). Strength is calculated as the sum of absolute edge values in a node and it signifies the 
magnitude of connections a node has to other nodes. When node strength is high, the node can 
influence many other nodes directly, and be influenced by them (Constantini et al., 2015). 
ExpectedInfluence is a relatively new centrality metrics which, like strength centrality, measures the 
overall connectivity of a node (Robinaugh, Millner & McNally, 2016). The difference to strength is 
that ExpectedInfluece accounts for whether the connection is negative or positive. Hence, 
ExpectedInfluence is especially informative in networks with negative edges.  
 
Following the guidelines of Epskamp, Borsboom and Fried (2018) centrality indices were estimated 
for stability, by using bootstrapping with the bootnet-package. 1,000 subsets were drawn from the 
original data and each time a different number of cases was dropped and the order of the indices 
recorded. Correlations for the order of the centrality indices were calculated between each subset and 
the original sample. The correlation stability coefficient (CS-coefficient; Epskamp, Borsboom & 
Fried, 2018) tells the maximum percentage of cases that can be dropped from the original sample to 
retain a correlation of 0.7 in at least 95% of the samples. I.e. a very low CS-coefficient means that 
the order of the indices is not stable or accurate even when a small drop in the sample is made. The 
CS-coefficient should be at least over 0.25 and preferably over 0.5 (Epskamp, Borsboom & Fried, 
2018). CS-coefficients were calculated for strength and ExpectedInfluence.  
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Predictability (Haslbeck & Waldorp, 2018) of nodes was estimated using the mgm-package in R. 
Predictability of an item (Haslbeck & Fried, 2017) tells how much of the variance of a single item is 
being explained by other items in the network. Predictability estimation ranges from 0 (node variance 
is not explained by other nodes) to 1 (node variance is explained perfectly by other nodes).  However, 
predictability cannot be estimated using polychoric correlations. Instead the mgm- function uses a 
Mixed Graphical Model (MGM) to estimate networks. MGM treats variables as continuous, and 
network estimation is based on the neighborhood regression approach. In order to interpret 
predictability estimates meaningfully, the MGM network should have the same structure to the GGM 
network.  
 
A community analysis was made using the R-package EGAnet (Golino & Christensen, 2019) using 
the function ‘EGA.' The Exploratory Graph Analysis technique (EGA: Golino & Epskamp, 2017) 
estimates the number of clusters of symptoms that interconnect more densely to each other, compared 
to the rest of the network. It also shows which items belong to each cluster. EGA is specifically 
designed for estimating the number of dimensions in a network structure, based on partial correlations 
with graphical Lasso regularization and EBIC selection. It uses the Walktrap algorithm for weighted 
undirected networks, which in short, uses random walks to find densely connected symptom 
communities (Pons & Latapy, 2005). It reveals groupings by getting trapped in them, rather than 
being able to move freely in the network from one community to another. 
4 RESULTS  
4.1 DESCRIPTIVE STATISTICS OF DEPRESSIVE SYMPTOMS 
Figure 1 shows the distributions and means of the four samples. Women showed significantly higher 
mean sum scores compared to men in both years (2007: p > .000; 2012: p > .033- .003). Women also 
showed a significant difference in the mean sum scores between 2007 and 2012 (p > .0142).  There 
was no significant difference in the mean sum scores in men between the two measuring points (p > 
.483). Figure 2 shows mean scores of each symptom and bootstrapped CIs in each sample. 12/21 
symptoms had significant differences between women and men in at least one possible comparison 
based on the bootstrapped CIs. In 6 symptoms, women had significantly higher means only in the 
2007 sample compared to men (“sadness,” “self-criticalness,” “agitation,” “indecisiveness,” “changes 
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in sleep,” “changes in appetite”). In 4 symptoms, women had significantly higher means compared 
to either one or both men's samples, but the differences were not significant in all comparisons 
(“guilty feelings,” “crying,” “loss of energy,” “irritability”). In 2/21 symptoms women had 
significantly higher means in all comparisons (“fatigue” and “loss of interest in sex”).   
 
 
Figure 1: Box-plot graph of depressive symptoms of men and women in two time-points. The horizontal lines 
depict median values. Means are shown as blue dots and presented in numbers. Dots outside the boxes  
represent outliers. 
 
 
 
Figure 2: Mean scores of BDI-II symptoms for men and women in two time-points.  The black bars indicate 
bootstrapped 95% confidence intervals  
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4.2 NETWORK ANALYSIS 
Figure 3 shows the estimated partial correlation networks of BDI-II symptoms for men and women 
in two time points. Centrality analysis results are shown in Figure 4 for both genders in two time 
points. CS-coefficients, which tell the stability of centrality were at good levels for ExpectedInfluence 
(.205-.439), but Strength centrality was under the recommended cut-off point of .25 (.128-.205), so 
only ExpectedInfluence centrality was assessed. Predictability of symptoms in the networks could 
not be meaningfully estimated, as there were visible differences in the network structure based on 
neighborhood regression (MGM) compared to the networks estimated using polychoric correlations 
(GGM). Estimated networks based on the EGA-community analysis are shown in figure 5. Table 1 
shows descriptive statistics for each network, with means and standard deviations.  
. 
 
 
 
Figure 3. Networks of BDI-II symptoms for men and women in two time points. The Fruchterman-Reingold 
algorithm makes stronger edges wider, and usually, more connected nodes are placed closer together. Positive 
edges are painted blue and negative edges red. 
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Figure 4: ExpectedInfluence centrality for men and women in two time points. Centrality estimates are shown 
in z-scores. 
 
 
Figure 5: EGA community structure of men and women. Colors reflect EGA clustering results.  
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Table 1      
Descriptive statistics of depressive symptoms of men and women in two time-points. 
  
 
Mean 
sum score 
SD Network 
density 
Node stability 
(CS-coefficient) 
Negative 
edges 
Women 2007 6.113  7.141 12.49  0.517  19,5 % 
Women 2012 5.327  6.683 12.11  0.283  13,1 % 
Men 2007 4.316  5.794 17.08  0.439  29,6 % 
Men 2012 4.573   6.592 22.78 0.283  33,7 % 
 
5 DISCUSSION 
5.1 SYMPTOM ARCHITECTURE OF MEN AND WOMEN 
5.1.1 Symptom severity 
In line with other studies on depression (Salk, Hyde, & Abramson, 2017), women reported more 
depressive symptoms and had higher mean sum scores compared to men (Figure 1). Women also had 
significantly higher means on several items compared to men (Figure 2). Most symptoms, which were 
reported higher among women were somatic and affective symptoms, including “fatigue,” “changes 
in appetite,” “irritability,” “loss of energy,” “crying,” “guilty feelings,” and “sadness.” Cognitive 
symptoms were reported in more similar levels between genders. The results support previous 
findings that women are more prone to report somatic symptoms and symptoms of atypical depression 
(Schuch et al., 2014; Marcus et al., 2005; Kroenke & Spitzer, 1998). Although many symptoms 
showed differences in severity between genders, when looking at the largest possible differences, 
“fatigue” and “loss of interest in sex” were the only symptoms that were reported consistently higher 
among women in all comparisons. As opposed to an earlier study with clinically depressed individuals 
(Schuch et al., 2014) men did not experience more sadness in this general population sample 
compared to women.  
5.1.2 Symptom centrality 
The mean value of a symptom was not predictive of symptom centrality. For example, most somatic 
symptoms in the women’s samples, such as “loss of interest in sex” were among the least central 
symptoms in the women’s networks. This implies that, for women, somatic symptoms did not share 
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much connectivity with the rest of the depressive symptoms in this study. “Fatigue” was the only 
central somatic symptom among women. It could be that, overall, somatic symptoms share more 
associations with other types of symptoms or factors. For example, it has been suggested that somatic 
symptoms could be explained by anxiety-related symptoms (Kapfhammer, 2006). Different 
underlying biological factors could also increase the likelihood of somatic symptoms in women. It 
has been suggested that the whole gender difference in depression is due to the higher rates of reported 
somatic symptoms in women (e.g. Silverstein, 2002), but these claims have also been criticized as 
unlikely to fully explain the different ratios of diagnoses and symptom severity (Delisle et al., 2012).  
 
For women, the centrality estimates were similar across time. Thus, associations between symptoms 
remained relatively stable as time had passed, even at low levels of symptom severity. For men, 
centrality estimates varied much more across time (Figure 4). For example, symptoms such as “lo of 
energy,” “past failure,” “self-dislike,” and “loss of interest” ranged from high centrality to low 
centrality in the men's two networks. Thus for men, at low levels of symptom severity, the 
relationships between symptoms varied much more compared to women. However, “sadness” and 
“worthlessness” were consistently high in centrality for both genders in both networks (Figure 4). 
Furthermore, “fatigue” and “agitation” differed in centrality between genders (Figure 4). 
 
Firstly, “fatigue” was highly central in both women’s networks but had low centrality in the men's 
networks. The finding that “fatigue” was highly central among women is in line with previous 
literature on fatigue. In general practice, women are observed to report more fatigue than men 
(Bensing, Hulsman, & Schreurs, 1999; Cullen, Kearney, & Bury, 2002). Reflecting on the high 
centrality of fatigue in the symptom network, women might be more prone to fatigue when other 
symptoms arise, and by experiencing more fatigue, women are more susceptible to develop 
depressive episodes. There is also evidence from previous network analysis studies that “fatigue” is 
associated with prospective depressive episodes (Boschloo, van Borkulo, Borsboom, & Schoevers, 
2016). A study which investigated the gender difference in “fatigue” based on the Dutch National 
Survey of Morbidity and Interventions in General Practice (men: n = 4,681; women: n = 4,698) 
analyzed different biological, psychological, and social factors relating to fatigue (Bensing, Hulsman, 
& Schreurs, 1999). Several factors were identified, which may underly the higher rates of fatigue 
among women, including child-care and employment. For men, fatigue was associated with more 
specific factors that limit functionality, such as having handicaps and severe chronic complaints. The 
authors emphasized that fatigue should be understood in a multicausal biopsychosocial framework. 
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Based on these results, enhancing our understanding of the etiology of fatigue (especially in women) 
could be a valuable direction in supporting the well-being of women.  
 
“Agitation” was the other symptom which showed a clear gender difference in centrality, being highly 
central for men in both time points, but having low centrality in the women’s networks. Interestingly, 
“agitation” is widely discussed in literature concerning suicide, as individuals who have died by 
suicide have often been characterized as physically or psychologically agitated (Busch, Fawcett, & 
Jacobs, 2003). It has long been acknowledged that men have higher suicide rates in most parts of the 
world; in Europe, the difference between genders is around 5:1 (WHO, 2017). “Agitation” has also 
been associated with a significantly higher risk of suicide attempt in men but not in women (Bryan et 
al., 2014). “Agitation” has also been shown to be especially central in a network analysis study on 
rapid-onset, acute suicidality (Rogers, Jom, & Hoiner, 2019). Thus, the high centrality of agitation 
among men could relate to processes which associate with suicidality of men. It should be noted that 
agitation may not in itself increase the risk of suicide. The effect of agitation may become relevant in 
the context where a person has developed the capacity to commit suicide (Ribeiro, Silva, & Joiner, 
2014). 
5.1.3 Network density 
Network density was higher in both of the men’s networks, compared to women’s networks (Figure 
3). The possibility to inspect networks in two time points revealed that men and women also had 
distinct developmental features in their symptom network structures. The most visible difference 
between genders was that, while women had a very similar network structure across time, density in 
the men’s network increased by 20% in the second measuring point compared to the first (Table 1). 
In contrast to network theory (Borsboom, 2017), symptom severity (sum scores) and network density 
showed no clear relationship. Although women showed higher mean values compared to men, the 
symptom networks of women were less dense and had weaker connections as the men’s networks 
(Table 1). Many of the symptoms such as “changes in appetite,” “crying,” and “sadness” were also 
among the symptoms that were visibly more connected in the men’s networks, although they were 
reported more by women. Furthermore, although women showed significant changes in the mean 
scores, there was no change in network density (Table 1). Thus, in this general population sample, 
network density did not reflect a more pathological network.  
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Previous results regarding network density have been mixed. There is some evidence that increased 
network density is associated with recovery. On the other hand, denser baseline networks are 
associated with later depressive episodes and worse prognosis. Yet, in other cases, density has been 
higher in the general population compared to clinical samples when other factors outside the network 
could explain symptom activation more. Sadly, it was not possible to estimate predictability in this 
study to confirm how much of the variation of a single symptom was explained by the other symptoms 
in the network. One explanation, which could account for the higher network density in men’s 
network in this study, could relate to the high number of negative connections in the men’s networks 
(Table 1). Negative connections imply that these symptoms are not reported together, as the increase 
in one symptom would mean a decrease in the other. It has been pointed out previously, that items 
with many or strong negative connections might not be highly problematic, but instead, diminish the 
effects of other items in the network it interacts with (Robinaugh, Millner & McNally, 2016). The 
negative edges in the men's networks might perhaps partly explain why a denser network in men does 
not result in a more pathological network. It could mean that the negative edges actually reflect a 
protective factor in men against developing depressive episodes.  
5.1.4 Community structure 
The main observation in the community analysis was that women had a more stable community 
structure across time compared to men. For women, depressive symptoms formed three distinct 
communities, which remained the same in both measuring points (Figure 5). Women reported these 
symptoms together more with each other than with other symptoms, although the formation of the 
community network evolved (greed and orange communities swapped over), and changes occurred 
in the connections both within and between clusters. Firstly, women reported co-occurring somatic-
affective symptoms characterized by low mood, irritation, and agitation (red community, Figure 5). 
Secondly, cognitive symptoms, such as worthlessness and self-dislike (first green then orange) 
formed a distinct community. Lastly, women reported somatic-affective symptoms together, which 
shared characteristics of anhedonia and problems with fatigue, sleep, indecisiveness, and appetite. 
Thus, the last community was associated most with atypical depression (first orange then green). For 
men, the community structures were more unstable. Both the number and type of symptoms changed 
within communities. As with women, cognitive symptoms associated consistently more with each 
other compared to other symptoms. Somatic and affective symptoms did not group consistently. For 
example, although sleep and appetite clustered together, atypical symptoms overall did not form a 
distinct community in both of the men’s networks.  
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5.2 IMPLICATIONS AND FUTURE DIRECTIONS 
The network analysis revealed distinct gender differences in the way depressive symptoms associated 
with each other in the general population. Women had a relatively stable network structure across 
time, unlike men. Thus, especially the network structure properties of women could form a basis for 
preventive action and further research in women’s depression. In the framework of network theory, 
the structure of the symptom network reflects how quickly an episode of psychopathology might 
emerge, and both local and global properties of the network can be inspected. For example, central 
symptoms of the network could be targeted in preventive actions. Targeting central symptoms is 
based on the idea that central symptoms can activate other symptoms more easily. By eliminating or 
hindering the activation of a central symptom from the symptom network, other connections in the 
network will not be activated or diminish as well.  
 
As “fatigue” was highly central for women, but not in men, it could prove an especially valuable 
target for preventive action in women’s depression. Thus, more research could focus specifically on 
factors relating to fatigue in women. It may be especially suitable to examine fatigue in a 
multidimensional model, where many types of factors could be examined together. More holistic 
networks have also been called for by the founders of the network approach (Fried & Cramer, 2017; 
Borsboom, Cramer, and Kalis, 2019). In this context, this could mean looking at fatigue along with 
social, physical or cognitive vulnerabilities and symptoms associated with fatigue across many 
diagnostic categories. The effects of central symptoms in depression could also be studied more in 
simulation studies. Simulations could give new insight into how a change in a central symptom would 
affect the rest of the network. The global structure, which included three distinct symptom 
communities in the women’s networks could provide an interesting topic for future research. For 
example, the community structure could be used in research relating to biological determinants of 
depression in projects like the RDoC (Woody & Gibb, 2015; Ahmed et al, 2018).  
 
More broadly, conceptualizing mental disorders as systems of symptoms has implications for clinical 
work as well. Patients could be given psychoeducation how different symptoms relate to one another, 
or central symptoms could be targeted in interventions for already depressed individuals. Temporal 
networks can already be created for individuals by collecting data with digital devices several times 
a day for a period of a week or two. These longitudinal networks provide specific information on the 
causal relationships of symptoms and the symptom network structures of individuals. Collecting more 
longitudinal group data is also important for developing a more accurate picture of how symptom 
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networks and specific symptoms trigger, maintain and deactivate episodes of psychopathology. 
Attaining such group data could consist of developing freely available online/mobile apps, where 
users could attain personal symptom networks and data could be gathered for research purposes. 
5.3 LIMITATIONS 
There are several limitations to this study. Firstly, there is the question of the appropriateness of the 
statistical method. The partial correlation network assumes a multivariate normal data. However, 
the current data is non-normal and strongly skewed to the right, as most responses cumulated on the 
lower end of the scale. The normality assumptions were relaxed in this study by assuming that the 
observed data was a transformation of a latent multivariate normally distributed system (Liu et al., 
2009). However, the model still assumes the latent variable to be normally distributed. It is quite 
plausible that at least some latent variables scores underlying observed variable scores, such as 
suicidal ideation are not normally distributed. Although partial correlation networks are widely used 
in the network literature, it is still an open question on how to best deal with non-normal data 
(Epskamp, 2017). One way to solve the issue is to dichotomize data and use network estimation, 
which is based on Ising models (vanBorkulo et al., 2014). Instead of correlations or partial 
correlations, network estimation for binary data is based on logistic regression and goodness of fit 
measures and is free from the normality assumptions linked to Gausal models. The two previous 
network studies of gender differences on depressive symptoms (one clinical and one non-clinical 
sample) are both based on Ising models. The two studies have found limited, if any, evidence of 
gender differences in the depressive symptom networks (vanBorkulo, 2017; Mullarkey, Marchetti 
& Beevers, 2018). 
 
For comparison, and to check whether the results would remain the same in this study, all networks 
were also estimated based on an Ising model and compared using the NCT for binary data 
(vanBorkulo, 2015). Based on NCT with binary data, there were no significant differences in the 
networks between men and women (results included in the Annex). There were also no negative 
edges in any network. Naturally, sensitivity is lost with binary data so the question is which method 
provides a more accurate picture of the true network. It could be that binary data is not sensitive 
enough to detect the gender differences found in the other analyses. Or, it could be that partial 
correlations are not suitable for such skewed data and/or when most of the data consists of zeros. In 
any case, there is a significant difference in the results based on the network estimation method.  
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Assuming that the partial correlation network gives us a more sensitive and a true reflection of 
symptom interaction, we still have the uncertainty of what centrality and density estimates actually 
tell us. According to network theory, associations between symptoms reflect causal relationships, 
instead of shared latent variables, and higher network density is associated with more pathological 
networks (Cramer, 2017). Results of this study suggest the opposite. However, direct causality 
between symptom interactions may not even be possible to assume. There is a multitude of options 
between the two extremes of systems of direct causality and common cause models (see Bringmann 
& Eronen, 2018). It has been shown that symptoms could have covariation due to a common factor, 
and a common cause does not prevent causal interaction between symptoms (Humphry & McGrain, 
2010). Also, symptoms do not have clear boundaries, but most likely overlap. For example, 
symptoms such as “fatigue” and “sleep problems,” or “irritation” and “agitation,” which had 
consistent strong connections in this study, might merely measure a common shared factor and 
inferring causal relationships between them is ambiguous (Bringmann and Eronen, 2018). To 
overcome this problem, Bringmann and Eronen (2018) have argued that there is no need to contrast 
latent variable models and network approach models. Instead, the focus should be on the symptom-
orientated approach and in studying psychopathology as a dynamic system, which evolves in time. 
There are already network studies, which focus on the temporal dynamics of symptoms, where 
causality can be investigated more accurately (e.g. Bringmann et al., 2015).  
 
More fundamental problems of the network analysis have been raised regarding cross-sectional and 
group level networks. For example, group-level networks might not reflect symptom associations at 
the level of the individuals (Bos & Wanders, 2016). Furthermore, it has been observed that cross-
sectional data does not reflect how symptoms trigger each other over time, as centrality measures 
are not concurrent when cross-sectional and temporal data are compared in the same study (Bos et 
al., 2017). Another limitation is how to estimate the meaningfulness of the network. Whether 
connections to other items explain 1% or 50% of an item's variance is highly relevant for making 
estimations on the meaningfulness of the network in practice (Haslbeck & Waldorp, 2018). As 
predictability estimates could not be applied to this data it is unclear how meaningful the estimated 
networks were.  
 
There are also limitations regarding depression research more generally, which relates to the 
problem of heterogeneity when measuring depression. A meta-analysis of data-driven studies on the 
factorial structure of common depression check-lists, shows large variation in the number and 
content of different factorial solutions the different studies yield (vanLoo et al., 2012). Similarly, 
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common rating scales seem to be lacking unidimensionality and longitudinal measurement 
invariance, meaning that the factorial structure of depressive symptoms is not the same even among 
the same people at different points in time (Fried et al, 2016b). This means that it is not clear what 
is being measured by common depression checklists. Current depression inventories include a 
mixture of mood, behavioral, somatic and cognitive symptoms in varying numbers and the selection 
of symptoms in a checklist might be based more on history and tradition rather than science (Santor, 
Gregus & Welch, 2006). Network analyses on depression check-list structures show that the 
centrality of items varies: where some items are highly central, some are much less so (Fried et al., 
2016; Kendler et al., 2018).  
 
The heterogeneity of measuring depression is especially tricky with network analysis. What items 
should be included in the analysis? Using the 21 preselected BDI-II symptoms inevitably result in a 
certain kind of network, which includes symptoms which may, or may not be important in the 
networks of depressive symptoms for men and/or women. A different selection of symptoms would 
have resulted in a different network. For example, ‘loneliness' is not included in the most used 
depression inventories, such as Hamilton Depression Rating Scale (HAM-D), Beck Depression 
Inventory (BDI), PHQ-9 or the Major Depression Inventory (MDI). However, loneliness is 
consistently associated with worse mental and physical health (Santini et al., 2016; Cacioppo et a., 
2006; Holt-Lunstad & Smit, 2010), and has been reported as a highly central symptom in the 
networks of adolescents and adults regarding depression (Mullarkey, Marchetti & Beevers, 2018; 
Santos et al, 2017). Similarly, anxiety-related symptoms are very common among depressed 
individuals, are more pronounced among women, and associated with worse outcomes (Howland et 
al., 2009). It has also been suggested that symptoms, such as “crying” and “increased appetite”, 
which are often reported more by women, might bias assessment on gender differences, as these 
symptoms could relate more to women in the first place (Romans, 2007). Thus, the results are only 
valid in the specific network context. There are also limitations associated with all self-reported 
measures. For example, it could be that differences between genders are due to different response 
styles between genders. However, research on the gender difference in depression is vast, and the 
results on the higher depression rates among women are consistent across nations.  
 
Future network analysis studies should focus on enhancing methodological and theoretical grounds, 
centrality estimates, and network analysis techniques, which could better account for psychological 
and mental health data. Developing network analysis on more solid theoretical grounds could 
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include building research on longitudinal temporal group data. Clearly, there are limitations to 
current inventories and methods, which should be given great attention. 
5.4 CONCLUSION 
The partial correlation depressive symptom networks of men and women showed distinct differences 
in connectivity and development across time. Although women showed alterations in the severity of 
symptoms, unlike men, the network structure remained relatively stable. For men, lower mean scores 
of depressive symptoms were linked to higher density, more negative connections, more variation in 
symptom centrality across time, and to a more evolving community structure. In the network theory 
framework, it could be that the pathways from symptoms to a depressive episode are more direct with 
women. Women’s networks also consisted of three distinct symptom clusters, which may reflect 
gender-specific emotional, cognitive, social or biological determinants, which make women more 
susceptible to depression. In contrast, negative connections in the men’s networks may hinder the co-
occurrence of different symptoms and reflect a protective factor men have in developing depression. 
“Fatigue” could play an especially important role in the development of depression in women, as it 
was highly central in the networks of women, but not in the men’s networks. Although there are still 
open questions relating to the network theory, the novel statistical methods have enabled fresh 
hypotheses and frameworks for understanding psychopathology. The network approach has created 
new avenues for research and enhanced knowledge about individual symptoms and their differences.  
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Appendix 
R Script 
# Creating data for women 2007 (W07) 
setwd("C:\\Users\\Tarja\\Documents\\Tarja\\Gradu\\R") 
library(foreign) 
all_data <- read.dta("C:\\Users\\Tarja\\Documents\\Tarja\\Gradu\\R\\saarela.dta") 
names <- c("Sadness", "Pessimism", "Past failure", "Loss of pleasure", "Guilty feelings", 
"Punishment feelings", "Self-dislike", "Self-criticalness", "Suicidal thoughts", "Crying", 
"Agitation", "Loss of Interest", "Indecisiveness", "Worthlessness", "Loss of Energy", "Sleep", 
"Irritability", "Appetite", "Concentration", "Fatigue", "Sex") 
 
data.W07 <- na.omit(subset(data, gender == 1,  
                                  select = colnames(data)[grep("_07", colnames(data))])) 
data.W12 <- na.omit(subset(data, gender == 1,  
                                  select = colnames(data)[grep("_12", colnames(data))])) 
data.M07 <- na.omit(subset(data, gender == 2,  
                                  select = colnames(data)[grep("_07", colnames(data))])) 
data.M12 <- na.omit(subset(data, gender == 2,  
                                  select = colnames(data)[grep("_12", colnames(data))])) 
 
# network estimation 
library(bootnet) 
networkW07 <- estimateNetwork(data.W07, default="EBICglasso", threshold = FALSE, 
corMethod="cor_auto", tuning=0.5) 
networkW12 <- estimateNetwork(data.W12, default="EBICglasso", threshold = FALSE, 
corMethod="cor_auto", tuning=0.5) 
networkM07 <- estimateNetwork(data.M07, default="EBICglasso", threshold = FALSE, 
corMethod="cor_auto", tuning=0.5) 
networkM12 <- estimateNetwork(data.M12, default="EBICglasso", threshold = FALSE, 
corMethod="cor_auto", tuning=0.5) 
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# attaining density and the number of negative and positive edges 
sum(abs(networkW07$graph))/2 #12.48532 
sum(abs(networkW12$graph))/2 #12.10573 
sum(abs(networkM07$graph))/2 #17.08223 
sum(abs(networkM12$graph))/2 #22.78138 
 
edgevalue_M07 <- networkM07$graph[upper.tri(networkM07$graph)] 
edgevalue_M12 <- networkM12$graph[upper.tri(networkM12$graph)] 
edgevalue_W07 <- networkW07$graph[upper.tri(networkW07$graph)] 
edgevalue_W12 <- networkW12$graph[upper.tri(networkW12$graph)] 
 
sum(edgevalue_M07!= 0)#tot 152 
sum(edgevalue_M07> 0) #pos 107 
sum(edgevalue_M07<0) #neg 45 
 
sum(edgevalue_M12!= 0)# tot 184 
sum(edgevalue_M12> 0) #pos 122 
sum(edgevalue_M12<0) #neg 62 
 
sum(edgevalue_W07!= 0) #tot 128 
sum(edgevalue_W07> 0) #pos 103 
sum(edgevalue_W07<0) #neg 25 
 
sum(edgevalue_W12!= 0) #tot 130  
sum(edgevalue_W12> 0) #pos 113 
sum(edgevalue_W12<0) #neg 17 
 
# plotting networks with average layout 
library(qgraph) 
Layout <- averageLayout(networkW07, networkM07, networkW12, networkM12, layout = 
"spring") 
layout(matrix(1:2, nrow =1)) 
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plot(networkW07, maximum= 0.62, cut= 0.15, layout = Layout, details= TRUE, labels = TRUE, 
vsize=6, title = "Women 2007", nodeNames = names, legend.cex = 0.4) 
plot(networkW12, maximum= 0.62, cut= 0.15, layout = Layout, details= TRUE, labels = TRUE, 
vsize=6, title = "Women 2012", nodeNames = names, legend.cex = 0.4) 
plot(networkM07, maximum= 0.62, cut= 0.15, layout = Layout, details= TRUE, labels = TRUE, 
vsize=6, title = "Men 2007", nodeNames = names, legend.cex = 0.4) 
plot(networkM12, maximum= 0.62, cut= 0.15, layout = Layout, details= TRUE, labels = TRUE, 
vsize=6, title = "Men 2012", nodeNames = names, legend.cex = 0.4) 
 
# centrality analysis  
centralityPlot(Year2007 = list(Men2007 = networkM07, Men2012 = networkM12), labels = names, 
include =c("ExpectedInfluence"), orderBy = "ExpectedInfluence") 
centralityPlot(Year2007 = list(Women2007 = networkW07, Women2012 = networkW12), labels = 
names, include =c("ExpectedInfluence"), orderBy = "ExpectedInfluence") 
 
centrality_auto(networkM07) 
centrality_auto(networkM12) 
centrality_auto(networkW07) 
centrality_auto(networkW12) 
 
nodebootM07 <- bootnet(networkM07, statistics =c("ExpectedInfluence", "Strength", 
"Betweenness", "Closeness"), type = "case") 
nodebootM12 <- bootnet(networkM12, statistics =c("ExpectedInfluence", "Strength", 
"Betweenness", "Closeness"), type = "case") 
nodebootW07 <- bootnet(networkW07, statistics =c("ExpectedInfluence", "Strength", 
"Betweenness", "Closeness"), type = "case") 
nodebootW12 <- bootnet(networkW12, statistics =c("ExpectedInfluence", "Strength", 
"Betweenness", "Closeness"), type = "case") 
 
# CS-coefficients  
corStability(nodebootM07) #ExpectedInfluence: 0.439, strength: 0.128  
corStability(nodebootM12) # ExpectedInfluence: 0.283, strenght: 0.128  
corStability(nodebootW07) # ExpectedInfluence: 0.517, strength: 0.128 
corStability(nodebootW12) # ExpectedInfluence: 0.283, strength: 0.205 
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# Community analysis 
install.packages("devtools") 
library("devtools") 
devtools::install_github('hfgolino/EGA') 
library("EGAnet") 
ega_M07<-EGA(data.M07, model = c("glasso"), plot.EGA = TRUE) 
ega_M12<-EGA(data.M12, model = c("glasso"), plot.EGA = TRUE) 
ega_W07<-EGA(data.W07, model = c("glasso"), plot.EGA = TRUE) 
ega_W12<-EGA(data.W12, model = c("glasso"), plot.EGA = TRUE) 
 
plot(ega_M07, layout = "Spring", labels = TRUE, vsize=6, border.width=1,5, nodeNames = names, 
legend.cex = 0.4, border.width=1.5, color=c("red", "green", "orange"), title = "Men 2007") 
plot(ega_M12, layout = "Spring", labels = TRUE, vsize=6, border.width=1.5, nodeNames = names, 
legend.cex = 0.4, border.width=1.5, color=c("red", "green", "orange"), title = "Men 2012") 
plot(ega_W07, layout = "Spring", labels = TRUE, vsize=6, border.width=1.5, nodeNames = names, 
legend.cex = 0.4, border.width=1.5, color=c("red", "green", "orange"), title = "Women 2007") 
plot(ega_W12, layout = "Spring", labels = TRUE, vsize=6, border.width=1.5, nodeNames = names, 
legend.cex = 0.4, border.width=1.5, color=c("red", "green", "orange", "white"), title = "Women 
2012") 
 
# Bootstrapped mean differences between W07 and M12 
x <- rowSums(data.W07) 
y <- rowSums(data.M12) 
pooled <- c(x, y) 
xt <- x - mean(x) + mean(pooled) 
yt <- y - mean(y) + mean(pooled) 
boot.t <- c(1:10000) 
for(i in 1:10000){ 
  sample.x <- sample(xt,replace=TRUE) 
  sample.y <- sample(yt,replace=TRUE) 
  boot.t[i] <- t.test(sample.x,sample.y)$statistic} 
p.h0 <-  (1 + sum(abs(boot.t) > abs(t.test(x,y)$statistic))) / (10000+1) 
p.h0 
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# Bootstrapped CIs 
data.list <- list(data.W07, data.W12, data.M07, data.M12) 
CI.data <- matrix(rep(0, times = 2*4*21), 8, 21) 
boot.means <- matrix(rep(0, times = 21*10000), 10000, 21) 
for(i in 1:4){ x.data <- data.list[[i]] for(q in 1:21){x <- x.data[,q]  
for(p in 1:10000){boot.means[p,q] <- mean(sample(x, replace = T))} 
boot.means[,q] <- sort(boot.means[,q]) 
CI.data[(i*2)-1, q] <- boot.means[250, q] 
CI.data[(i*2), q] <- boot.means[9750, q]} 
} 
rownames(CI.data) <- c("W07 Lower", "W07 Upper", "W12 Lower", "W12 Upper", "M07 Lower", 
"M07 Upper", "M12 Lower", "M12 Upper") 
 
# The Ising model 
# creating binary data 
data.W07.di <- apply(data.W07, c(1,2), function(x){ifelse(x<1, 0, 1)}) 
data.W12.di <- apply(data.W12, c(1,2), function(x){ifelse(x<1, 0, 1)}) 
data.M07.di <- apply(data.M07, c(1,2), function(x){ifelse(x<1, 0, 1)}) 
data.M12.di <- apply(data.M12, c(1,2), function(x){ifelse(x<1, 0, 1)}) 
 
# network estimation and plotting 
library(IsingFit) 
library(qgraph) 
resM07.di <- IsingFit(as.matrix(data.M07.di),gamma = 0.25, plot=FALSE) 
resM12.di <- IsingFit(as.matrix(data.M12.di),gamma = 0.25, plot=FALSE) 
resW07.di <- IsingFit(as.matrix(data.W07.di),gamma = 0.25, plot=FALSE) 
resW12.di <- IsingFit(as.matrix(data.W12.di),gamma = 0.25, plot=FALSE) 
 
GraphW07.di <- qgraph(resW07.di$weiadj, layout="spring", maximum= 2.41, cut=.15, details= 
TRUE, labels = TRUE, vsize=6, title = "Women 2007", nodeNames = names, legend.cex = 0.4) 
GraphW12.di <- qgraph(resW12.di$weiadj, layout="spring", maximum= 2.41, cut=.15, details= 
TRUE, labels = TRUE, vsize=6, title = "Women 2012", nodeNames = names, legend.cex = 0.4) 
GraphM07.di <- qgraph(resM07.di$weiadj, layout="spring", maximum= 2.41, cut=.15, details= 
TRUE, labels = TRUE, vsize=6, title = "Men 2007", nodeNames = names, legend.cex = 0.4) 
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GraphM12.di <- qgraph(resM12.di$weiadj, layout="spring", maximum= 2.41, cut=.15, details= 
TRUE, labels = TRUE, vsize=6, title = "Men 2012", nodeNames = names, legend.cex = 0.4) 
 
# NCT (Ising model) 
library(NetworkComparisonTest) 
 
# Women 2007 - Men 2007: 
NCTW07M07 <- NCT(data.M07.di, data.W07.di, it= 1000, binary.data= TRUE, paired= TRUE, 
test.edges= TRUE, edges= "all") 
 
NCTW07M07$glstrinv.sep # densities 46.24660 49.91756 
NCTW07M07$glstrinv.real # difference 3.670964 
NCTW07M07$glstrinv.pva # p-value 0.312 
 
# Women 2007 – Men 2012 
NCTW07M12 <- NCT(data.M12.di, data.W07.di, it= 1000, binary.data= TRUE, paired= TRUE,  
test.edges= TRUE, edges= "all") 
 
NCTW07M12$glstrinv.sep # 50.21134 49.91756 
NCTW07M12$glstrinv.real # 0.2937802 
NCTW07M12$glstrinv.pva # 0.928 
 
# Women 2012 - Men 2007: 
NCT_W12_M07 <- NCT(data.M07.di, data.W12.di, it= 1000, binary.data= TRUE, paired= TRUE, 
test.edges= TRUE, edges= "all") 
 
NCTW12M07$glstrinv.sep # densities 46.24660 49.64927 
NCTW12M07$glstrinv.real #difference 3.402677 
NCTW12M07$glstrinv.pva #p-value of difference 0.384 
 
# Women 2012 – Men 2012 
NCTW12M12 <- NCT(data.M12.di, data.W12.di, it= 1000, binary.data= TRUE, paired= TRUE, 
test.edges= TRUE, edges= "all") 
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NCTW12M12$glstrinv.sep # densities 50.21134 49.64927 
NCTW12M12$glstrinv.real #difference 0.5620673 
NCTW12M12$glstrinv.pva #p-value 0.884 
 
 
 
 
